246 related articles for article (PubMed ID: 32319385)
1. [Clinical Characteristics and Prognosis of 56 Lymphoma Patients with Mediastinal Masses].
Yu H; Wang L; Zhu HY; Wu W; Liang JH; Yin H; Fan L; Li JY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):495-499. PubMed ID: 32319385
[TBL] [Abstract][Full Text] [Related]
2. Mediastinal Gray Zone Lymphoma: A Wider Category Than We Think?
Verma A; Shet T; Epari S; Gupta M; Gujral S; Khanna N; Laskar S; Sengar M; Arora B; Menon H; Banavali S
Int J Surg Pathol; 2016 Aug; 24(5):382-93. PubMed ID: 26957476
[TBL] [Abstract][Full Text] [Related]
3. Pediatric gray zone lymphoma according to the 2022 WHO classification: An Italian cohort study.
Restivo GA; Farruggia P; Pillon M; Mascarin M; Elia C; Recupero S; Muggeo P; Cagnazzo C; Onofrillo D; Mura R; Furfari I; Trizzino A; Bertolini P; Sala A; De Santis R; Galimberti D; Schiavello E; Carraro E;
Pediatr Blood Cancer; 2023 May; ():e30481. PubMed ID: 37254478
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and safety of programmed death-1 inhibitor in the treatment of relapsed/refractory classical Hodgkin's lymphoma].
Shan DD; Liu HM; Liu W; Huang WY; Lyu R; Deng SH; Yi SH; An G; Xu Y; Sui WW; Wang TY; Fu MW; Zhao YZ; Qiu LG; Zou DH
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):555-560. PubMed ID: 37749034
[No Abstract] [Full Text] [Related]
6. Long-term complete remission following tandem autologous stem cell transplantation and consolidative radiotherapy for refractory mediastinal gray-zone lymphoma.
Takaishi K; Muto T; Mimura N; Takiguchi J; Nagao Y; Oshima-Hasegawa N; Tsukamoto S; Takeda Y; Mitsukawa S; Takeuchi M; Ohwada C; Ota S; Iseki T; Nakaseko C; Sakaida E
Int J Hematol; 2018 Oct; 108(4):452-455. PubMed ID: 29786758
[TBL] [Abstract][Full Text] [Related]
7. [Clinical and pathological characteristics and prognosis analysis of gray zone lymphoma].
Liu SZ; Zong XP; Cai WZ; He HJ; Ma ZX; Li JQ; Li CX; Wu DP
Zhonghua Yi Xue Za Zhi; 2024 Jan; 104(1):69-73. PubMed ID: 38178771
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant.
Pasvolsky O; Bassett RL; Ghanem S; Cuglievan B; Tewari P; Hosing C; Srour S; Ramdial J; Mahadeo KM; Khazal S; Petropoulos D; Popat U; Qazilbash M; Kebriaei P; Champlin R; Shpall EJ; Nieto Y
BMC Cancer; 2023 Dec; 23(1):1258. PubMed ID: 38124057
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal Gray Zone Lymphoma with Features Intermediate between Classical Hodgkin Lymphoma and Primary Mediastinal B-Cell Lymphoma.
Song HN; Kim SJ; Ko YH; Kim WS
Acta Haematol; 2016; 136(3):186-90. PubMed ID: 27623181
[TBL] [Abstract][Full Text] [Related]
10. [Programmed cell death-1 inhibitor combined with rituximab in refractory or relapsed diffuse large B-cell lymphoma: a preliminary efficacy and safety analysis].
Qin Y; Zhao FY; Zhou Y; Jiang SY; Yang S; Shi YK
Zhonghua Zhong Liu Za Zhi; 2020 Dec; 42(12):1034-1039. PubMed ID: 33342160
[No Abstract] [Full Text] [Related]
11. [A clinical analysis of 10 cases with cardiac lymphoma].
Li YH; Shi CY; Duan FQ; Pang Y; Li HB; Zhang LQ; Liu ZH; Ouyang L; Yue CY; Xie MC; Jiang ZJ; Xiao Y
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):102-106. PubMed ID: 28279032
[No Abstract] [Full Text] [Related]
12. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
Lerner RE; Thomas W; Defor TE; Weisdorf DJ; Burns LJ
Biol Blood Marrow Transplant; 2007 Apr; 13(4):486-92. PubMed ID: 17382255
[TBL] [Abstract][Full Text] [Related]
13. [Outcomes of 33 patients with anaplastic large cell lymphoma treated after hematopoietic stem cell transplantation].
Lu N; Li XF; Dong YJ; Wang YN; Fu XR; Wu YM; Li YH; Wang MH; Li NN; Ren HY; Wang Z; Zhang MZ; Wu XX; Hu LD; Liu Y; Huang WR
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):117-122. PubMed ID: 32135627
[No Abstract] [Full Text] [Related]
14. A retrospective analysis of outcomes for primary mediastinal large B-cell lymphoma treated with RCHOP followed by radiotherapy or front-line autologous stem cell transplantation.
Liu X; Deng T; Guo X; Guo Y; Wang L; Zhang J; Xia Z; Zhang Q; Xue K; Cao J; Shi J; Hong X
Hematology; 2017 Jun; 22(5):258-264. PubMed ID: 27884092
[TBL] [Abstract][Full Text] [Related]
15. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
[TBL] [Abstract][Full Text] [Related]
16. [Clinical Efficacy of Autologous Hematopoietic Stem Cell Transplantation for Patients with Diffuse Large B-Cell Lymphoma].
Fan D; Liu Q; Xiao F; Guo HX; Zhao H; Yan XQ; Liu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1163-1168. PubMed ID: 34362497
[TBL] [Abstract][Full Text] [Related]
17. High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma.
Wen Q; Gao L; Xiong JK; Li Q; Wang SB; Wang JS; Liu F; Zhang C; Liu Y; Kong PY; Peng XG; Rao J; Gao L; Zhang X
Curr Med Sci; 2021 Jun; 41(3):465-473. PubMed ID: 34218355
[TBL] [Abstract][Full Text] [Related]
18. [Influence of transplantation and some clinical factors on prognosis of patients with diffuse large B-cell lymphoma].
Zhao SX; Han Y; Zhu Q; Wang Q; Zhang WJ; Chen XC; Sun AN; Jin ZM; Qiu HY; Tang XW; Fu ZZ; He GS; Miao M; Ma X; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):623-7. PubMed ID: 23815910
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of treatment with dose-adjusted EPOCH-R or R-CHOP in primary mediastinal large B-cell lymphoma.
Malenda A; Kołkowska-Leśniak A; Puła B; Długosz-Danecka M; Chełstowska M; Końska A; Giza A; Lech-Marańda E; Jurczak W; Warzocha K
Eur J Haematol; 2020 Jan; 104(1):59-66. PubMed ID: 31606909
[TBL] [Abstract][Full Text] [Related]
20. The significance of upfront autologous stem cell transplantation for high-intermediate/high-risk stage IV diffuse large B-cell lymphoma.
Koviazin AK; Filatova LV; Zyuzgin IS; Artemyeva AS; Poliatskin IL; Burda DS; Volchenkov SA; Elkhova SS; Semiglazova TY
Cancer Rep (Hoboken); 2023 Apr; 6(4):e1786. PubMed ID: 36855295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
